Search Publications
Export 7 results:
Author Title [ Year(Asc)]
Filters: Keyword is Triple Negative Breast Neoplasms  [Clear All Filters]
Pérez-Núñez I, Rozalén C, Palomeque JÁngel, Sangrador I, Dalmau M, Comerma L, et al.. LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer. Nat Cancer. 2022 ;3(3):355-370.
Tang Y, Kang Y. Microbial metabolite as icebreaker for immunotherapy. Cell Metab. 2022 ;34(4):506-507.
Shen M, Wei Y, Kim H, Wan L, Jiang Y-Z, Hang X, et al. Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis. Nat Cancer. 2022 ;3(1):43-59.
Meng J, Jiang Y-Z, Zhao S, Tao Y, Zhang T, Wang X, et al. Tumor-derived Jagged1 promotes cancer progression through immune evasion. Cell Rep. 2022 ;38(10):110492.
Ghergurovich JM, Lang JD, Levin MK, Briones N, Facista SJ, Mueller C, et al. Local production of lactate, ribose phosphate, and amino acids within human triple-negative breast cancer. Med (N Y). 2021 ;2(6):736-754.
Ghergurovich JM, Esposito M, Chen Z, Wang JZ, Bhatt V, Lan T, et al. Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis. Cancer Res. 2020 ;80(18):3820-3829.
Shen M, Jiang Y-Z, Wei Y, Ell B, Sheng X, Esposito M, et al. Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling. Cancer Cell. 2019 ;35(1):64-80.e7.